BRIEF published on 08/14/2026 at 09:05, 1 month 10 days ago Eckert & Ziegler SE : Une croissance solide malgré les défis Évaluation Des Actions Produits Isotopiques Croissance Médicale Eckert Et Ziegler Résultats Du Premier Semestre 2026
BRIEF published on 08/14/2026 at 09:05, 1 month 10 days ago Eckert & Ziegler SE: Solid Growth Despite Challenges Eckert & Ziegler Stock Valuation Isotope Products Medical Growth H1 2026 Results
PRESS RELEASE published on 08/14/2026 at 09:00, 1 month 10 days ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY NuWays AG releases updated research classified Eckert & Ziegler SE as a BUY with target price EUR 21.5. H1 results show solid growth in medical and isotope products segments with confirmed FY26 guidance Buy Recommendation NuWays AG Eckert & Ziegler SE H1 Results FY26 Guidance
BRIEF published on 08/13/2026 at 07:50, 1 month 11 days ago Eckert & Ziegler maintient le cap au premier semestre 2026 Résultats Financiers Prévisions De Bénéfices Segment Médical Eckert Et Ziegler Premier Semestre 2026
BRIEF published on 08/13/2026 at 07:50, 1 month 11 days ago Eckert & Ziegler Maintains Course in First Half of 2026 Financial Results Eckert & Ziegler Profit Forecast Medical Segment First Half 2026
PRESS RELEASE published on 08/13/2026 at 07:45, 1 month 11 days ago Eckert & Ziegler Remains on Track in the First Half of 2026 Eckert & Ziegler SE reports stable financial results for the first half of 2026 with sales of €149.3 million and net income of €22.4 million. The company confirms its forecast for the year 2026 Financial Results Sales Forecast Eckert & Ziegler SE First Half 2026
BRIEF published on 07/23/2026 at 09:06, 2 months 1 day ago Competitive Dynamics in the Radiopharmaceutical Market: Eckert & Ziegler's Strategy Eckert & Ziegler Radiopharmaceuticals Competition Lu-177 Growth Ga-68 Market
BRIEF published on 07/23/2026 at 09:06, 2 months 1 day ago Dynamique concurrentielle sur le marché des produits radiopharmaceutiques : la stratégie d'Eckert & Ziegler Produits Radiopharmaceutiques Concours Eckert Et Ziegler Croissance Lu-177 Marché Ga-68
PRESS RELEASE published on 07/23/2026 at 09:01, 2 months 1 day ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY Research update on Eckert & Ziegler SE highlights strong Ga-68 outlook amid competition, with projected growth in Ga-68 sales and potential Lu-177 upside. Details of the analysis provided in the press release Research Update Market Analysis Ga-68 Eckert & Ziegler SE Lu-177
BRIEF published on 07/22/2026 at 07:31, 2 months 2 days ago BaFin's Review of Eckert & Ziegler's 2024 Financial Statements Financial Statements Discontinued Operations BaFin Review Pentixapharm Spin-off Operating Key Figures
Published on 09/25/2026 at 00:30, 4 hours 39 minutes ago Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Published on 09/25/2026 at 00:15, 4 hours 54 minutes ago CoTec Holdings Corp. Announces Extension of Private Placement of Unsecured Convertible Debentures
Published on 09/24/2026 at 22:01, 7 hours 8 minutes ago Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/24/2026 at 14:55, 14 hours 14 minutes ago Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements
Published on 09/25/2026 at 02:45, 2 hours 24 minutes ago Huagui Group: un acteur mondial sur deux marchés aquatiques de plus de 100 milliards de RMB, tandis que la racine de lotus de Honghu se classe au premier rang pour sa teneur en antioxydants
Published on 09/25/2026 at 02:45, 2 hours 24 minutes ago Huagui Group: A Global Player Across Two RMB100-Billion Aquatic Markets, as Honghu Lotus Root Ranks No. 1 in Antioxidant Content
Published on 09/24/2026 at 20:29, 8 hours 40 minutes ago EQS-Adhoc: HelloFresh SE expects revenue for Q3 2026 below market expectations and adjusts outlook for the financial year 2026
Published on 09/24/2026 at 19:00, 10 hours 9 minutes ago HIAG provides a first-hand insight into its strategy and the added value it generates at its Capital Market Day
Published on 09/24/2026 at 18:40, 10 hours 28 minutes ago EQS-Adhoc: Brockhaus Technologies AG launches public share buyback offer of approx. €90 million for up to 3,592,000 shares
Published on 09/24/2026 at 18:31, 10 hours 38 minutes ago LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:00, 11 hours 9 minutes ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 11 hours 9 minutes ago GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026